MAP 2018 – Molecular Analysis for Personalised Therapy Congress

The development of new biotechnologies and their application to precision medicine in cancer treatment is a fast-moving field. Understanding molecular alterations, their mechanisms of action and how they can apply to therapy is a challenge in medical oncology and clinical practice.

MAP 2018, in Paris, France, on September 14-15th, will be the place for Medical Oncologists and stake holders to acquire the most recent knowledge in precision medicine. 

Learning objectives

• Therapeutics targets in various tumour types and the use of genomic profiling for treatment selection
• Clonal evolution
• Use of mathematical modelling and artificial intelligence as tools for disease evolution
• The impact of micro satellite instability testing across tumour types
• The role of virus in carcinogenesis and the impact of gut microbiota in immune treatment efficacy
• The development of precision immuno-oncology
• The design of innovative trials for better outcome achievements